Highest levels of NMU expression were detected in HER2-enriched and basal-like breast carcinomas as well as advanced tumors of larger size, proposing a possible positive selection of NMU expressing cancer cells in advanced tumor stages. The gene discussed is ERBB2; the disease is breast carcinoma.